Loading...
XHKG
6108
Market cap7mUSD
Oct 28, Last price  
0.35HKD
1D
0.00%
1Q
73.27%
Jan 2017
-89.49%
IPO
-99.42%
Name

New Ray Medicine International Holding Ltd

Chart & performance

D1W1MN
XHKG:6108 chart
P/E
—
P/S
—
EPS
Vol. 1Y
464.26%
Shs. 5Y
—
Rev. 5Y
-14.06%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.

Key people

Kwok Wa Lai
Financial Controller, Company Secretary
Zhihong Huo
Chief Executive Officer, Executive Director · since 2018
Chik Yuet Lee
Executive Director
Qiuqin Wang
Executive Director · since 2018
Linxing Hua He
Director of subsidiaries of the Company
Yang Liu
Executive Chairman of the Board · since 2018
Chi Kin Leung
Non-Executive Independent Director · since 2013
Sin Ming Li
Non-Executive Independent Director · since 2017
Independent Non-Executive Director · since 2018
IPO date
Oct 25, 2013
Employees
Domiciled in
CN
Incorporated in
BM

Valuation

No data to show